Genomic landscape of adenoid cystic carcinoma of the breast
about
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.Uterine adenosarcomas are mesenchymal neoplasms.Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphologyInfiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profileMicroglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.The impact of the MYB-NFIB fusion proto-oncogene in vivo.Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.Adenoid cystic carcinoma: emerging role of translocations and gene fusionsLeiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.Genetic alterations in salivary gland cancers.Triple negative breast cancer: the kiss of death.Emerging themes of regulation at the Golgi.The importance of regulatory ubiquitination in cancer and metastasis.The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma.Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.AKT3 drives adenoid cystic carcinoma development in salivary glands.MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.Contralateral breast cancers: Independent cancers or metastases?Emerging Opportunities for Target Discovery in Rare Cancers.SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients.Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast.Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making.Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort.Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.Splicing dysregulation as a driver of breast cancer
P2860
Q33915057-6614FAD2-67F5-4F53-9DF4-4502DA2E703BQ35848142-2B1D910A-301C-4316-BEF0-C44DDBF9284EQ36844915-84A98ECF-8541-4C42-B948-1A82522F146CQ37119308-6942EFEE-BC7E-442F-8236-9E03E49AE1C0Q37130372-7896E313-1679-463A-B578-F304A8A09E4CQ37362488-7D1BFF91-6B1A-4621-B33F-3C836B2CC7D3Q37372455-E4B1F2D4-63CB-4862-8661-E0EDC0A41115Q37662396-2617D824-20A2-478F-A2B8-B00F0B13D0CDQ38700667-F2BF13DD-20E9-4FC6-9A35-8C695B961E1CQ38755879-67EA1BBA-F049-4511-A90C-E15A0576FF1FQ38818744-611112C1-FBA4-49A8-899B-DC82FB4374EFQ38954641-432F6466-DE5D-445B-8CAE-BA38B1F868D3Q39122602-9076A60B-8652-4FC2-859E-5D7CFA52E8A8Q39453298-B003FF4B-99BD-4911-9DBC-D762AE1F57CEQ41194627-522C6439-A19F-443D-B1C2-B94EA7D1C449Q41195725-8F2A134A-7C0B-41A4-BCD9-469DA17840FAQ41455794-88952587-940A-49DC-8F3F-2D7379BC48D9Q42510239-05DBAB3E-6699-4F38-ADED-3D30ACE3267FQ45048187-D3E5F106-0429-40A7-B19F-B5342066F971Q45073569-C7C9225C-452A-478B-912C-E1FFACFA5ED1Q47240501-C8AF0F0D-6E84-47BF-8AB3-D3964911CF28Q47391427-D0D4A4B3-5EBD-4855-AF65-B1ACC28FB334Q47683672-47A4AE80-6768-4D18-9585-C51FBE48879DQ47941750-CA8B0C73-43FE-46BA-B695-2768C582C868Q49569462-8CF1D335-C0F4-4AFF-A336-67318135469BQ49716898-2F92DA5A-8518-4248-8578-385C389B67A7Q49884832-3E7E364C-AB94-4504-A57A-63A55007D835Q50144412-B7FFF14B-D2FB-4F30-A0E7-1A8082E30510Q52611827-32A97CD8-7A84-40F5-A46E-6C0138DD39A2Q52726975-40401CE7-4D5E-4FA3-950B-D10CC3EA1ED9Q55003632-8E6CA0A2-3F52-416E-9DAB-F57352018986Q55353370-41CAF9D5-9980-4E51-979E-79534392AC1CQ57106833-239F32B4-7586-44EF-8132-86B83EE39266
P2860
Genomic landscape of adenoid cystic carcinoma of the breast
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Genomic landscape of adenoid cystic carcinoma of the breast
@ast
Genomic landscape of adenoid cystic carcinoma of the breast
@en
type
label
Genomic landscape of adenoid cystic carcinoma of the breast
@ast
Genomic landscape of adenoid cystic carcinoma of the breast
@en
prefLabel
Genomic landscape of adenoid cystic carcinoma of the breast
@ast
Genomic landscape of adenoid cystic carcinoma of the breast
@en
P2093
P2860
P50
P356
P1476
Genomic landscape of adenoid cystic carcinoma of the breast
@en
P2093
Anne M Schultheis
Göran Stenman
Huei-Chi Wen
Joanna Cyrta
Laetitia Fuhrmann
Maria R De Filippo
Odette Mariani
Pierre-Emmanuel Colombo
Ronglai Shen
Timothy A Chan
P2860
P304
P356
10.1002/PATH.4573
P50
P577
2015-06-12T00:00:00Z